See historicals and forecasts on 32 key metrics for Biogen


Name Type
Cost And Expenses: Acquired In-process Research And Development Annual
Cost And Expenses: Amortization And Impairment Of Acquired Intangible Assets Annual
Cost And Expenses: Amortization Of Acquired Intangible Assets Annual
Cost And Expenses: Collaboration Profit Sharing Annual
Cost And Expenses: Cost Of Sales Annual
Cost And Expenses: Cost Of Sales Excluding Amortization Of Acquired Intangible Assets Annual
Cost And Expenses: Loss On Fair Value Remeasurement Of Contingent Consideration Annual
Cost And Expenses: Research And Development Annual
Cost And Expenses: Restructuring Charges Annual
Cost And Expenses: Selling General And Administrative Annual
Cost And Expenses: Tecfidera Litigation Settlement And License Charges Annual
Cost And Expenses: Total Cost And Expenses Annual
Earnings Per Share: Basic Annual
Earnings Per Share: Diluted Annual
EBITDA Annual
Equity In Loss Of Investee Net Of Tax Annual
Gain On Sale Of Rights Annual
Income From Operations Annual
Income Tax Expense Annual
Net Income Annual
Net Income Attributable To Biogen Inc. Annual
Net Income Attributable To Noncontrolling Interests Net Of Tax Annual
Nonoperating Income Annual
Other Revenue: Product Revenues Annual
Product Net: Product Revenues Annual
Revenues From Anti-cd20 Therapeutic Programs: Product Revenues Annual
Revenues: Other Annual
Revenues: Product Net Annual
Revenues: Total Revenues Annual
Revenues: Total Revenues From Anti-cd20 Therapeutic Programs Annual
Weighted-average Shares Used In Calculating: Basic Earnings Per Share Attributable To Biogen Inc. Annual
Weighted-average Shares Used In Calculating: Diluted Earnings Per Share Attributable To Biogen Inc. Annual